Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on WT1/IL15/IL15Ra mRNA DC Vaccine for Patients with Advanced or Refractory Solid Tumors of the Pancreas, Esophagus, Liver, or Ovaries

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Belgium Denmark France The Netherlands
  • Study of Regorafenib and Avelumab for Adults with Advanced or Metastatic Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Belgium France Italy Spain
  • Study of MK-7684A and Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Italy The Netherlands Poland Spain
  • Study on the Safety of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    Croatia Cyprus Greece Spain
  • Study of Futibatinib with Pembrolizumab and Chemotherapy for Patients with Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Spain
  • Study of erdafitinib treatment for adults and adolescents with advanced solid tumors having FGFR gene changes

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Study of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated Diseases:
    Belgium France Germany Italy Poland Spain
  • Study on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer

    Not recruiting

    1 1 1 1
    Belgium Czechia France Germany Hungary Italy +2